Details of the Drug

General Information of Drug (ID: DMEPJ7C)

Drug Name
BI 905677
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
DTB43H

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
LDL receptor related protein-6 (LRP-6) TTSXOWE LRP6_HUMAN Antagonist [2]
Low-density lipoprotein receptor-related protein 5 (LRP5) TT7VMG4 LRP5_HUMAN Antagonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03604445) This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Boehringer Ingelheim.